M&G Investment Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-76,304
Closed -$3.81K 602
2021
Q3
$3.81K Buy
76,304
+9,060
+13% +$494K 0.01% 449
2021
Q2
$3.77K Buy
+67,244
New +$3.58M 0.01% 436

Other funds holding HCAT

M&G Investment Management's HCAT Position: Q4 2021 in Review

M&G Investment Management sold out of Health Catalyst (HCAT) in Q4 2021, closing a stake of 76,304 shares — an estimated $3.81K sold.

M&G Investment Management first reported a position in HCAT in Q2 2021 and held it in 2 quarters. The position peaked at $3.81K in Q3 2021. 186 funds tracked by Wall St. Rank hold HCAT as of Q4 2021.

  • M&G Investment Management reported no remaining Health Catalyst position as of Q4 2021 after selling out during the quarter.
  • M&G Investment Management sold 76,304 Health Catalyst shares in Q4 2021, an estimated $3.81K.
  • M&G Investment Management first reported a position in Health Catalyst in Q2 2021 and held it in 2 quarters.
  • M&G Investment Management's Health Catalyst position peaked at $3.81K in Q3 2021.
  • 186 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2021.

Based on M&G Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.